title: Important considerations in the design of iron oxide nanoparticles as contrast agents for TI-weighted MRI and MRA.
authors.affiliation: Nycomed Amersham Imaging, Wayne, PA, USA.
authors.forename: Kenneth E
authors.initials: KE
authors.lastname: Kellar
authors.forename: Dennis K
authors.initials: DK
authors.lastname: Fujii
authors.forename: Wolfgang H H
authors.initials: WH
authors.lastname: Gunther
authors.forename: Karen
authors.initials: K
authors.lastname: Briley-Saebø
authors.forename: Atle
authors.initials: A
authors.lastname: Bjornerod
authors.forename: Marga
authors.initials: M
authors.lastname: Spiller
authors.forename: Seymour H
authors.initials: SH
authors.lastname: Koenig
mesh_terms: D003287:Contrast Media / Q000737:chemistry*; D003911:Dextrans; D052203:Ferrosoferric Oxide; D007501:Iron / Q000737:chemistry*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009682:Magnetic Resonance Spectroscopy; D058185:Magnetite Nanoparticles; D010087:Oxides / Q000737:chemistry*
chemical_list: D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; C097921:ferumoxtran-10; D007501:Iron; D052203:Ferrosoferric Oxide